The Fred Hutchinson Cancer Research Center’s Dr. Catherine Blish is the recipient of an Interscience Conference on Antimicrobial Agents and Chemotherapy Young Investigator Award from the American Society for Microbiology for her work elucidating the role of neutralizing antibodies in HIV transmission.
Antiretroviral therapy associated with 92 percent decreased risk of HIV transmission among HIV-1 discordant couples in large, multinational study
June 1, 2010
Research led by Dr. Deborah Donnell of the Vaccine and Infectious Disease Institute at the Fred Hutchinson Cancer Research Center has found that treating HIV-infected persons with antiretroviral therapy (ART) reduces HIV transmission to their sexual partners by more than 90 percent.
VIDI’s Elizabeth Brown studies mother-to-child transmission of HIV and more to make a difference in peoples’ lives
June 22, 2009
| By Rachel Tompa
From mother-to-child transmission of HIV to coronary artery lesions, Dr. Elizabeth Brown of the Fred Hutchinson Cancer Research Center loves a statistical challenge. And the more uncertain, the better—that’s where she believes good statistics can really make a difference.